Cargando…

Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact

INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodhar, Divya, Varghese, George, Balaji, Veeraraghavan, John, James, Rebekah, Grace, Janardhanan, Jeshina, Jeyaraman, Ranjith, Jasmine, Sudha, Mathews, Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557147/
https://www.ncbi.nlm.nih.gov/pubmed/26392716
http://dx.doi.org/10.4103/0974-777X.162234
_version_ 1782388462751580160
author Deodhar, Divya
Varghese, George
Balaji, Veeraraghavan
John, James
Rebekah, Grace
Janardhanan, Jeshina
Jeyaraman, Ranjith
Jasmine, Sudha
Mathews, Prasad
author_facet Deodhar, Divya
Varghese, George
Balaji, Veeraraghavan
John, James
Rebekah, Grace
Janardhanan, Jeshina
Jeyaraman, Ranjith
Jasmine, Sudha
Mathews, Prasad
author_sort Deodhar, Divya
collection PubMed
description INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur at almost all sites of the body. Hence, SAB is associated with increased morbidity and mortality in spite of appropriate antimicrobial treatment. The virulence in S. aureus is determined by the presence of adhesins and toxins, which behave like superantigens (SAgs) and leads to a massive release of proinflammatory cytokines causing overwhelming inflammatory response leading to endothelial leakage, hemodynamic shock, multiorgan failure, and possibly death. MATERIALS AND METHODS: One year prospective study conducted in a tertiary care hospital in southern part of India included all patients with SAB. Clinical details were filled according to. All isolates were subjected to polymerase chain reaction (PCR) for enterotoxin profiling. RESULTS: A total of 101 patients of SAB were identified which comprises of 61 (60.4%) patients with methicillin-susceptible S. aureus (MSSA) and 40 (39.6%) patients with methicillin-resistant S. aureus (MRSA). Most common predictors of mortality were prior hospitalization and antibiotic intake, severe organ dysfunction, shock, tachycardia, and leukocytosis. Two-third of the isolates had at least one enterotoxin, most prevalent was sea; 28% and 27% (P - value = 0.001) MSSA isolates had seg and sei; whereas, 38.6% (P - value < 0.001) of MRSA isolates were found to have sea. The most common enterotoxin associated with mortality was sei, which comprised of 38% of all mortality. CONCLUSION: In SAB, the significant predictors of mortality were prior hospitalization and antibiotic intake, presence of multiorgan dysfunction, and shock. Although overall significance between the enterotoxin and shock could not be demonstrated, it successfully demonstrated the difference of enterotoxin between MSSA and MRSA.
format Online
Article
Text
id pubmed-4557147
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45571472015-09-21 Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact Deodhar, Divya Varghese, George Balaji, Veeraraghavan John, James Rebekah, Grace Janardhanan, Jeshina Jeyaraman, Ranjith Jasmine, Sudha Mathews, Prasad J Glob Infect Dis Original Article INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur at almost all sites of the body. Hence, SAB is associated with increased morbidity and mortality in spite of appropriate antimicrobial treatment. The virulence in S. aureus is determined by the presence of adhesins and toxins, which behave like superantigens (SAgs) and leads to a massive release of proinflammatory cytokines causing overwhelming inflammatory response leading to endothelial leakage, hemodynamic shock, multiorgan failure, and possibly death. MATERIALS AND METHODS: One year prospective study conducted in a tertiary care hospital in southern part of India included all patients with SAB. Clinical details were filled according to. All isolates were subjected to polymerase chain reaction (PCR) for enterotoxin profiling. RESULTS: A total of 101 patients of SAB were identified which comprises of 61 (60.4%) patients with methicillin-susceptible S. aureus (MSSA) and 40 (39.6%) patients with methicillin-resistant S. aureus (MRSA). Most common predictors of mortality were prior hospitalization and antibiotic intake, severe organ dysfunction, shock, tachycardia, and leukocytosis. Two-third of the isolates had at least one enterotoxin, most prevalent was sea; 28% and 27% (P - value = 0.001) MSSA isolates had seg and sei; whereas, 38.6% (P - value < 0.001) of MRSA isolates were found to have sea. The most common enterotoxin associated with mortality was sei, which comprised of 38% of all mortality. CONCLUSION: In SAB, the significant predictors of mortality were prior hospitalization and antibiotic intake, presence of multiorgan dysfunction, and shock. Although overall significance between the enterotoxin and shock could not be demonstrated, it successfully demonstrated the difference of enterotoxin between MSSA and MRSA. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4557147/ /pubmed/26392716 http://dx.doi.org/10.4103/0974-777X.162234 Text en Copyright: © Journal of Global Infectious Diseases http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Deodhar, Divya
Varghese, George
Balaji, Veeraraghavan
John, James
Rebekah, Grace
Janardhanan, Jeshina
Jeyaraman, Ranjith
Jasmine, Sudha
Mathews, Prasad
Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title_full Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title_fullStr Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title_full_unstemmed Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title_short Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
title_sort prevalence of toxin genes among the clinical isolates of staphylococcus aureus and its clinical impact
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557147/
https://www.ncbi.nlm.nih.gov/pubmed/26392716
http://dx.doi.org/10.4103/0974-777X.162234
work_keys_str_mv AT deodhardivya prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT varghesegeorge prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT balajiveeraraghavan prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT johnjames prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT rebekahgrace prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT janardhananjeshina prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT jeyaramanranjith prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT jasminesudha prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact
AT mathewsprasad prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact